BE904586A - Urogastrone. - Google Patents

Urogastrone.

Info

Publication number
BE904586A
BE904586A BE0/216524A BE216524A BE904586A BE 904586 A BE904586 A BE 904586A BE 0/216524 A BE0/216524 A BE 0/216524A BE 216524 A BE216524 A BE 216524A BE 904586 A BE904586 A BE 904586A
Authority
BE
Belgium
Prior art keywords
urogastrone
site
medicament
human urogastrone
homeothermic
Prior art date
Application number
BE0/216524A
Other languages
English (en)
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of BE904586A publication Critical patent/BE904586A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Utilisation de l'urogastrone humaine ou d'un fragment d'urogastrone humaine pour la préparation d'un médicament propre à favoriser la régénération osseuse et/ou tendineuse. Le médicament se prete à l'administration topique ou parentérale et est administré par préférence directement au site de la lésion ou à un site qui en est fort proche. Ce médicament convient de façon générale pour tous les organismes homéothermes.
BE0/216524A 1985-04-12 1986-04-11 Urogastrone. BE904586A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858509448A GB8509448D0 (en) 1985-04-12 1985-04-12 Urogastrone

Publications (1)

Publication Number Publication Date
BE904586A true BE904586A (fr) 1986-10-13

Family

ID=10577560

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216524A BE904586A (fr) 1985-04-12 1986-04-11 Urogastrone.

Country Status (7)

Country Link
US (1) US4731357A (fr)
JP (1) JPS61293925A (fr)
BE (1) BE904586A (fr)
DE (1) DE3612232A1 (fr)
FR (1) FR2580175B1 (fr)
GB (2) GB8509448D0 (fr)
IT (1) IT1188650B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5070188A (en) * 1989-07-24 1991-12-03 Ethicon, Inc. Acylated epidermal growth factor
US5219998A (en) * 1990-06-04 1993-06-15 Levin Robert H Yeast-derived epidermal growth factor
ES2145740T3 (es) * 1990-08-02 2000-07-16 Indu Parikh Composiciones de factor de crecimiento, preparacion y uso.
US5434135A (en) * 1990-08-02 1995-07-18 Indu Parikh Growth factor compositions, preparation and use
US5741895A (en) * 1990-08-21 1998-04-21 The Regents Of The University Of California Identification of cell density signal molecule
RU2136308C1 (ru) * 1994-11-16 1999-09-10 Жемчугов Владислав Евгеньевич Стимулятор роста костно-мозговых клеток человека
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1394846A (en) * 1972-11-29 1975-05-21 Ici Ltd Polypeptides
DE3382562D1 (de) * 1982-09-24 1992-06-25 Us Health Wiederherstellung von gewebe bei tieren.

Also Published As

Publication number Publication date
GB8509448D0 (en) 1985-05-15
FR2580175A1 (fr) 1986-10-17
IT1188650B (it) 1988-01-20
GB2173700A (en) 1986-10-22
DE3612232A1 (de) 1986-10-16
IT8620063A0 (it) 1986-04-11
US4731357A (en) 1988-03-15
FR2580175B1 (fr) 1990-03-02
GB8608730D0 (en) 1986-05-14
GB2173700B (en) 1989-06-21
JPS61293925A (ja) 1986-12-24
IT8620063A1 (it) 1987-10-11

Similar Documents

Publication Publication Date Title
FI103180B (fi) Flurbiprofeenia sisältävien lääkkeiden valmistus kipujen ja/tai tulehd usten torjumiseksi eläimissä ja ihmisissä
IT1199760B (it) Dispositivo terapeutico per la somministrazione di medicamenti
DE3680943D1 (de) Therapeutische mittel zur oralen verabreichung.
FI904092A7 (fi) Lääkevalmisteita ankarien kiputilojen käsittelyyn ja menetelmä niiden valmistamiseksi
IT8647603A0 (it) Procedimento di trattamento per forme farmaceutiche di dosaggio rivestite per ridurne la collosita'
DE68910159D1 (de) Dosierform für Verabreichung in der Humanmedizin.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
DE69308388D1 (de) Derivate von nicht-steroidalen entzündungshemmenden analgetischen und/oder antipyretischen Arzneimitteln, ihre Verwendung und diese enthaltende pharmazeutische Zubereitungen
EP0177342A3 (fr) Formulations orales de protéines thérapeutiques
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
ES2032272T3 (es) Empleo de factor b inductor de cartilago (cif-b) para la elaboracion de medicamentos para impedir el crecimiento tumoral.
BE904586A (fr) Urogastrone.
DE69004532D1 (de) Topisch anzuwendende Defibrotid enthaltende Arzneizubereitungen.
DE68909267D1 (de) Medikament zur Behandlung von fibrotischer Störung und antifibrotische Verbindung.
FI913625A0 (fi) Behandling av nedsatt funktion av leukocyter med gm-csf.
PT91049B (pt) Dispositivo para administracao oral de um medicamento aum animal ruminante
BG44709A3 (bg) Метод за получаване на 9-хлор-1,5-бензотиазепинови производни
IT1190471B (it) Preparato per la cura e l'igiene della bocca
EP0279867A3 (fr) Emploi de vitamine E et association de vitamine E avec des antiphlogistiques et analgésique pour le traitement de maladies rhumatismales
EG17992A (en) Preparation of a medicament for arthritis and theumatism
FR2578745B1 (fr) Preparations pharmaceutiques fluidifiant le sang
IT1214915B (it) Derivato dell'acido 4-metossiisoftalico con attivita'farmacologica in disordini tromboembolici e procedimento per la sua preparazione
SE8704081D0 (sv) A new prohylactic method
FR2568124B1 (fr) Medicament pour traiter les etats hypotrophiques par administrations d'aspartate d'arginine
OA09469A (fr) Utilisation d'un polypeptide ayant l'activité de l'interféron gamma pour la préparation de compositions pharmaceutiques destinées au traitement de cancers primitifs de la plèvre.

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: IMPERIAL CHEMICAL INDUSTRIES PLC

Effective date: 19940430